InMed Pharmaceuticals informa las ganancias trimestralmente. Estos informes de ganancias trimestrales ofrecen a los inversores una visión de los resultados financieros de una empresa durante un período de 3 meses. Los informes de ganancias casi siempre incluyen resultados de EPS e ingresos.
Analice el historial de beneficios de InMed Pharmaceuticals utilizando filtros y clasificaciones avanzadas.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
INM | InMed Pharmaceuticals | -$2.71 | — | — | — | $1.26M | — | — | — | 11/13/2025 | |
INM | InMed Pharmaceuticals | -$3.80 | — | -$0.43 | — | $1.28M | — | $1.30M | — | 09/23/2025 | |
INM | InMed Pharmaceuticals | -$3.60 | — | -$1.94 | — | $1.17M | — | $1.26M | — | 05/12/2025 | |
INM | InMed Pharmaceuticals | -$3.80 | — | -$3.64 | — | $1.24M | — | $1.11M | — | 02/12/2025 | |
INM | InMed Pharmaceuticals | -$15.20 | — | -$2.71 | — | $901.86K | — | $1.26M | — | 11/14/2024 | |
INM | InMed Pharmaceuticals | -$3.80 | — | -$3.80 | — | $1.24M | — | $1.28M | — | 09/30/2024 | |
INM | InMed Pharmaceuticals | -$12.00 | — | -$3.60 | — | $1.03M | — | $1.17M | — | 05/14/2024 | |
INM | InMed Pharmaceuticals | -$18.20 | — | -$3.80 | — | $469.78K | $1.39M | $1.24M | -10.79% | 02/13/2024 | |
INM | InMed Pharmaceuticals | -$81.20 | — | -$15.20 | — | $320.79K | — | $901.86K | — | 11/14/2023 | |
INM | InMed Pharmaceuticals | -$258.40 | — | $5.60 | — | $514.76K | — | $2.31M | — | 09/19/2023 | |
INM | InMed Pharmaceuticals | -$125.00 | — | -$12.00 | — | $309.58K | — | $1.03M | — | 05/15/2023 | |
INM | InMed Pharmaceuticals | -$155.00 | — | -$18.20 | — | $265.09K | — | $469.78K | — | 02/17/2023 | |
INM | InMed Pharmaceuticals | -$125.00 | — | -$81.20 | — | $0.00 | — | $320.79K | — | 11/11/2022 | |
INM | InMed Pharmaceuticals | -$205.00 | -$5.50 | -$258.40 | -4598.18% | $0.00 | $750.00K | $514.76K | -31.37% | 09/23/2022 | |
INM | InMed Pharmaceuticals | -$205.00 | — | -$125.00 | — | $0.00 | — | $309.58K | — | 05/13/2022 | |
INM | InMed Pharmaceuticals | -$185.00 | -$5.75 | -$155.00 | -2595.65% | $0.00 | $120.00K | $265.09K | 120.91% | 02/14/2022 | |
INM | InMed Pharmaceuticals | -$155.00 | — | -$125.00 | — | $0.00 | — | $0.00 | — | 11/10/2021 | |
INM | InMed Pharmaceuticals | — | — | -$205.00 | — | — | — | $0.00 | — | 09/24/2021 | |
INM | InMed Pharmaceuticals | -$195.00 | — | -$205.00 | — | — | — | $0.00 | — | 05/13/2021 | |
INM | InMed Pharmaceuticals | — | — | -$185.00 | — | — | — | $0.00 | — | 02/11/2021 | |
INM | InMed Pharmaceuticals | -$325.00 | — | -$155.00 | — | $0.00 | — | $0.00 | — | 11/13/2020 |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q4 | 2022-09-23 | $-258.40 | $-5.50 | -4598.2 % |
| Q2 | 2022-02-14 | $-155.00 | $-5.75 | -2595.6 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q2 | 2024-02-13 | $1.24M | $1.39M | -10.8 % |
| Q4 | 2022-09-23 | $514.76K | $750.00K | -31.4 % |
| Q2 | 2022-02-14 | $265.09K | $120.00K | 120.9 % |
Está previsto que InMed Pharmaceuticals (INM) presente resultados el noviembre 13, 2025. Los últimos resultados se publicaron el septiembre 23, 2025 para el Q4.
El BPA real fue de $-0.43, que no alcanzó la estimación de $0.00.
Los ingresos reales fueron $1.3M, que superó la estimación de $0K.
Explora Estimaciones de beneficios, BPA e ingresos sobre todos los valores.